Next Article in Journal
Growth Factor-Induced Vascular Smooth Muscle Cell Proliferation is Inhibited by Tylophorine
Previous Article in Journal
Distinct Anti-Migratory Effects of Resveratrol on EGF- versus PDGF-Stimulated Vascular Smooth Muscle Cells
Article Menu

Article Versions

Export Article

Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2015). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Open AccessAbstract
Sci. Pharm. 2009, 77(Posters (PO)), 244; https://doi.org/10.3797/scipharm.oephg.21.PO-45 (registering DOI)

Indirubine-3-Monoxime Inhibits PDGF-Mediated Vascular Smooth Muscle Cell Migration

Department of Pharmacognosy, University of Vienna, Althanstr. 14, 1090, Vienna, Austria
*
Author to whom correspondence should be addressed.
Received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009
PDF [199 KB, uploaded 12 May 2017]

Abstract

During the pathology of atherosclerosis and restenosis, hyperproliferation and migration of vascular smooth muscle cells (VSMC) contribute to lumen loss of the vessel and neointima formation [1]. Drugs interfering with both, proliferation and migration of VSMC are therefore promising candidates for the treatment of vasculoproliferative diseases.
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

SROKA, I.; HEISS, E.H.; CZALOUN, C.; DIRSCH, V.M. Indirubine-3-Monoxime Inhibits PDGF-Mediated Vascular Smooth Muscle Cell Migration. Sci. Pharm. 2009, 77, 244.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top